Home About Us Contact Us

 

Table of Content Volume 15 Issue 3 - September 2020


Spontaneous spinal epidural hematoma in a patient on oral anticoagulant (Dabigatran)

 

Mustafa Taskeen1*, Dileep Kadam2, Shreyas Wajekar3

 

1Junior Resident, 2Professor, 3Junior Resident, Department of Medicine, Smt Kashibai Navale Medical College and Research Center, Narhe Ambegaon Pune 411041, INDIA.

Email: drmustafataskeen@gmail.com

 

REFERENCES

  1. Kim KT, Cho DC, Ahn SW, Kang SH. Epidural hematoma related with low-dose aspirin: complete recovery without surgical treatment. J Korean Neurosurg Soc 2012;51:308–311.
  2. Yang SM, Kang SH, Kim KT, Park SW, Lee WS. Spontaneous spinal epidural hematomas associated with acute myocardial infarction treatment. Korean Circ J 2011;41:759–762
  3. Shin JJ, Kuh SU, Cho YE. Surgical management of spontaneous spinal epidural hematoma. Eur Spine J. 2006;15:998e1004.
  4. Y. M. Mekaj, A. Y. Mekaj, S. B. Duci, and E. I. Miftari, “New oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic events,” Therapeutics and Clinical Risk Management, vol. 11, pp. 967–977, 2015.
  5. J. M. Castillo, H. F. Afanador, E. Manjarrez, and X. A. Morales, “Non-traumatic spontaneous spinal subdural hematoma in a patient with non-valvular atrial fibrillation during treatment with rivaroxaban,” American Journal of Case Reports, vol. 16, pp. 377–381, 2015.
  6. C. Dargazanli, N. Lonjon, and G. Gras-Combe, “Nontraumatic spinal subdural hematoma complicating direct factor Xa inhibitor treatment (rivaroxaban): a challenging management,” European Spine Journal, vol. 25, no. 1, pp. 1–4, 2016.
  7. M. Zaarour, S. Hassan, N. Thumallapally, and Q. Dai, “Rivaroxaban-induced nontraumatic spinal subdural hematoma: an uncommon yet life-threatening complication,” Case Reports in Hematology, vol. 2015, Article ID 275380, 5 pages, 2015.
  8. Pradaxa US Prescribing Information. Ridgefield: Boehringer Ingelheim Pharmaceuticals, Inc; 2015. Available at: http://docs.boehringer-ingelheim.com/Prescribing Information/PIs/Pradaxa/Pradaxa.pdf.
  9. Stangier J. Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate. Clin Pharmacokinet. 2008; 47:285–295.
  10. Douxfils J, Mullier F, Robert S, Chatelain C, Chatelain B, Dogne JM. Impact of dabigatran on a large panel of routine or specific coagulation assays. Laboratory recommendations for monitoring of dabigatran etexilate. Thromb Haemost. 2012;107:985–997.
  11. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, et al... Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361:1139e51.
  12. PRADAXA® (dabigatran etexilate mesylate) capsules, for oral use Initial U.S. Approval: 2010 accessed from www.fda.gov/medwatch.
  13. Binder KD, D Sonne C, Lawton TM. Spinal epidural hematoma. Neurosurg Q. 2004;14:51e59.
  14. V.B. Moises Heleno, B. Raphael, Conservative treatment of large spontaneous spinal extradural hematoma, Arq. Neuropsiquiatr. 68 (2010) 130–131.
  15. J. G. Heckmann, “Spinal subarachnoid haemorrhage in cortical superficial siderosis after apixaban and clopidogrel therapy,” Journal of Thrombosis and Thrombolysis, vol. 41, no. 4, pp. 654-655, 2016.
  16. Hadley MN, Walters BC. Guidelines for the management of acute cervical spine and spinal cord injuries. Neurosurgery. 2013;72:1e259.
  17. P. Gelosa, L. Castiglioni, M. Tenconi et al..., “Pharmacokinetic drug interactions of the non-vitamin K antagonist oral anticoagulants (NOACs),” Pharmacological Research, vol. 135, pp. 60–79, 2018.